tiprankstipranks
Nektar initiates Phase 2b clinical study of alopecia areata candidate
PremiumThe FlyNektar initiates Phase 2b clinical study of alopecia areata candidate
2M ago
Nektar reports Q4 EPS (22c), consensus (21c)
PremiumThe Fly
Nektar reports Q4 EPS (22c), consensus (21c)
2M ago
Nektar options imply 26.2% move in share price post-earnings
PremiumThe Fly
Nektar options imply 26.2% move in share price post-earnings
2M ago
Nektar to present NKTR-255 combo poster at ASH meeting
PremiumThe FlyNektar to present NKTR-255 combo poster at ASH meeting
4M ago
Nektar reinstated with an Underweight at JPMorgan
PremiumThe Fly
Nektar reinstated with an Underweight at JPMorgan
5M ago
Nektar upgraded to Outperform from Market Perform at TD Cowen
PremiumThe Fly
Nektar upgraded to Outperform from Market Perform at TD Cowen
6M ago
Nektar presents new responder data for rezpegaldesleukin
PremiumThe FlyNektar presents new responder data for rezpegaldesleukin
6M ago
Nektar enters into new clinical study collaboration with CBMG
PremiumThe Fly
Nektar enters into new clinical study collaboration with CBMG
7M ago
Nektar announces ‘promising’ data from Phase 1b study of Rezpegaldesleukin
PremiumThe Fly
Nektar announces ‘promising’ data from Phase 1b study of Rezpegaldesleukin
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100